The U.S. must do some heavy lifting to prepare for heritable genome editing
By Josephine Johston,
STAT
| 09. 04. 2020
Countries contemplating giving the green light to heritable genome editing received specific guidance from an international commission this week on how to prepare for a future in which the technology is safe and effective enough to use in human reproduction.
The commission was created in response to the news almost two years ago that a scientist in China had edited the genomes of two babies when they were single-cell embryos. (It subsequently emerged that a third baby with an edited genome had been born.)
While the scientist involved, He Jiankui, was widely condemned for conducting a premature and unethical experiment, and later fined and sentenced to jail, his first-in-humans experiment pushed the international community beyond a “germline editing — good or bad?” discussion to actively considering what it would take to justify its use.
Germline gene editing raises particular ethical and safety issues. Gene editing in a young child or adult creates changes that may affect the individual, but are not passed on to his or her children. Germline editing, also known as heritable genome editing, creates changes that...
Related Articles
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In 2025, we published up to four posts every month, written by 12 authors (staff, consultants and allies), some in collaboration and one simply credited to CGS.
These titles are presented in chronological order, except for three In Memoriam notices, which follow. Many more posts that are worth your time can be found in the archive. Scroll down and “VIEW...
By Jonathan Matthews, GMWatch | 12.11.2025
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation campaign, in which transgenic cloned grey wolves have been showcased to the world as resurrected dire wolves – a...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...
By Simar Bajaj, The New York Times | 11.27.2025
A common cold was enough to kill Cora Oakley.
Born in Morristown, N.J., with virtually no immune system, Cora was diagnosed with severe combined immunodeficiency, a rare genetic condition that leaves the body without key white blood cells.
It’s better...